Delivery Order SPE2D021D0005-SPE2D326F2218
Award Date 12/8/25
Potential Completion Date 12/11/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to Genentech USA, Inc. for Tamiflu (oseltamivir) 75 mg capsules with a contract ceiling value of $1,387.32. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 9, 2025, represents a small targeted procurement of antiviral medication. The award was made without a set-aside designation, indicating open competition. Genentech USA, Inc., a foreign-owned...
- Genentech USA, Inc., a foreign-owned pharmaceutical manufacturer headquartered in South San Francisco, California, received a $45.1 million delivery order from the Office of the Assistant Secretary for Preparedness and Response (ASPR) for Oseltamivir Phosphate (Tamiflu) 30mg and 75mg capsules. Awarded on January 30, 2025, with an ultimate completion date of June 6, 2025, this firm fixed-price contract utilizes no set-aside designation and is issued under Genentech's existing Pharmaceuticals...
- The Defense Logistics Agency Troop Support Medical awarded a $228,798.54 firm-fixed-price delivery order contract to Genentech USA, Inc. for the procurement of the antiviral medication oseltamivir phosphate. As a prime contractor, Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals, will deliver the drug to support the agency's medical mission. The agency did not use a set-aside for this contract. Genentech has previously provided various biologic medicines, including...
- This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...
- This federal contract award, valued at $2,241.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Tamiflu 75 mg capsules, a medication used to treat and prevent influenza. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 11, 2022. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime...
- The Defense Logistics Agency awarded a delivery order valued at $11,716.94 to AmerisourceBergen Drug Corp for the supply of Oseltamivir 75mg in unit dose packages of 10 units. This is a firm fixed price, non-set-aside contract with a completion date of December 30, 2025, and was awarded on December 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used for influenza treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $5,201.74 to AmerisourceBergen Drug Corp for Oseltamivir Phosphate 75 mg capsule unit dose packages (10s) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Oseltamivir is an antiviral medication commonly used to treat and prevent influenza, representing a...
- The Defense Logistics Agency awarded a $3,288.91 delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packs of 10. The contract is a firm fixed-price arrangement with a completion date of December 19, 2025, and carries no set-aside designation, indicating it was awarded through competitive procurement. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packaging of 10 tablets, with a ceiling value of $59,932.80 and an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Oseltamivir, an antiviral medication...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 26, 2025, for the supply of Oseltamivir Phosphate 75 mg capsules in unit dose packages of 10, with a contract ceiling value of $14,569.51 and an ultimate completion date of December 29, 2025. This firm fixed price delivery order, which is not associated with a set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Oseltamivir is an...